Surface Electrical Stimulation for Treatment of Phantom Limb Pain
EPIONE
Natural Sensory Feedback for Phantom Limb Modulation and Therapy
2 other identifiers
interventional
20
1 country
1
Brief Summary
Phantom limb pain (PLP) is a frequent consequence of amputation, and it is notoriously difficult to treat. Amputation usually follows traumatic injuries or surgery following vascular diseases, diabetes, osteomyelitis or tumours in cases where the loss of the limb is required for the survival of the patient. The loss of a limb or other body parts is usually followed by the sensation that the lost body part is still present and can be felt. These phenomena are called, respectively, phantom awareness and phantom sensation. In 50-80% of amputees neuropathic pain develops in the lost limb also referred to as phantom limb pain (PLP). PLP can be related to a certain position or movement of the phantom limb, and might be elicited or worsened by a range of physical factors (e.g. changes in the weather or pressure on the residual limb) and psychological factors (e.g. emotional stress). It is well known that most treatments available for PLP today, such as pharmacological, surgical, anaesthetic, psychological and other, are ineffective. Today it is believed that phantom limb pain may be related to changes in the cortex of the brain. There is evidence that these changes may be modulated - or even reversed - by providing sensory input to the stump or amputation zone. For example, cortical reorganization and alleviation of phantom limb pain has been observed in amputees following intense use of a hand prosthesis. However, there is no consistent knowledge on which type of peripheral sensory feedback may be effective in affecting the cortical plasticity or on how to best apply the sensory feedback. The aim of the proposed research is to create natural, meaningful sensations through providing non-invasive sensory feedback (i.e. surface electrical stimulation) and the effectiveness to alleviate phantom limb pain and restore the cortical neuroplastic changes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2015
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2015
CompletedFirst Submitted
Initial submission to the registry
June 30, 2015
CompletedFirst Posted
Study publicly available on registry
July 2, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2017
CompletedNovember 14, 2017
November 1, 2017
2.3 years
June 30, 2015
November 10, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Phantom limb pain
The pain intensity will be assessed using a visual analog scale (VAS)
Change in pain perception over three months
Cortical reorganization
The cortical response to peripheral stimulation will be tracked using MRI
Change in cortical reorganization over three months
Secondary Outcomes (2)
Cortical reorganization
Change in cortical reorganization over three months
Phantom limb pain
Change in neuropathic pain symptoms over three months
Study Arms (1)
Surface Electrical Stimulation
EXPERIMENTALPlease see information under 'Detailed description'
Interventions
Surface electrical stimulation using the following devices; 1) INOMED surface stimulator, 2) The EPIONE Psychophysical Testing Platform software for stimulator control. Surface stimulation therapy is provided while providing visual guidance to the subject.
Eligibility Criteria
You may qualify if:
- Amputation of one or both arms below the shoulder level or amputation of one or both legs below hip joint
- Total or partial peripheral nerve injury (i.e.,under spinal cord level) causing paralysis of the arms or legs
- Other treatments for phantom limb pain should have been tried with poor results
- The subject should experience phantom limb pain at a level of 6 or higher measured on on a visual analog scale (VAS) ranging from 0-10
- Phantom limb pain should be experienced at least once a week
- The subject should be in a chronic and stable phase, and the stump should have healed
- The subject should otherwise be healthy and able to carry out the experiment
- If pain medication is used it will be acceptable that the person continues to use the medication
- It should, through peripheral electrical stimulation, be possible to apply the relevant phantom emotions to the subject
You may not qualify if:
- Cognitive impairment
- Pregnancy
- Prior or current psychological diseases such as borderline, schizophrenia, depression or manic-depressive
- Acquired brain injury with residual impairment
- Prior neurological or musculoskeletal diseases
- History of or active substance abuse disorder
- Persons with that experience an allergic reaction to surface electrodes
- Persons with fear for electrical stimulation or pain
- Persons that are hypersensitive to electrical stimulation and experience the stimulation as unpleasant
- Persons that feel may claustrophobic in an MRI scanner
- Persons that have metal parts in the body (such as pacemakers or metal screws)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Winnie Jensenlead
- Aalborg University Hospitalcollaborator
- University of Lausanne Hospitalscollaborator
- University of Freiburgcollaborator
- Université Montpelliercollaborator
- Lund Universitycollaborator
- Indiana University School of Medicinecollaborator
- Novosense ABcollaborator
- Mxm-Obeliacollaborator
- Ecole Polytechnique Fédérale de Lausannecollaborator
- Universitat Autonoma de Barcelonacollaborator
- Catholic University of the Sacred Heartcollaborator
Study Sites (1)
Winnie Jensen
Aalborg, Denmark
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Winnie Jensen, Ph.D
Aalborg University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
June 30, 2015
First Posted
July 2, 2015
Study Start
June 1, 2015
Primary Completion
September 1, 2017
Study Completion
September 1, 2017
Last Updated
November 14, 2017
Record last verified: 2017-11